Condition
Hypersomnolence
Total Trials
4
Recruiting
1
Active
1
Completed
2
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 4 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 2 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
3Total
Not Applicable (3)
Trial Status
Completed2
Suspended1
Recruiting1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 2 completed trials
Clinical Trials (4)
Showing 4 of 4 trials
NCT05066009Not ApplicableCompletedPrimary
Sleep/Wake State Assessment with Non-invasive Earbuds
NCT06457945Not ApplicableRecruiting
Mind-wandering and Predictive Processes in Narcolepsy: a Putative Mechanism Through Covert REM Intrusions
NCT04419792Suspended
'A Profile of Physical Performance Variables in an Out-patient Adult Population With Narcolepsy'
NCT00174174Not ApplicableCompleted
Provigil (Modafinil) Study by Taiwan Biotech Co.
Showing all 4 trials